Literature DB >> 2411245

Is bivalent binding of monoclonal antibodies to different antigenic areas on the hemagglutinin of influenza virus required for neutralization of viral infectivity?

S Yoden, H Kida, R Yanagawa.   

Abstract

Biological activities of Fab fragments of monoclonal IgG antibodies to each of four nonoverlapping antigenic areas on the hemagglutinin molecule of A/seal/Massachusetts/1/80 (H7N7) influenza virus were examined. Fab fragments of the antibodies belonging to groups I and II neutralized viral infectivity. These Fab fragments inhibited hemagglutination of the virus and virus-induced hemolysis at pH 5.9. On the other hand, Fab fragments of groups III and IV antibodies showed neither neutralization nor hemolysis-inhibition activities, while intact IgG molecules of groups III and IV effectively neutralized viral infectivity and inhibited virus-induced hemolysis, as previously found. These IgG molecules scarcely or did not inhibit hemagglutination of the virus. Neutralization of viral infectivity, however, was observed when the virus was coated with Fab fragments of groups III and IV antibodies and then incubated with anti-Fab fragment antibodies. These findings suggest that bivalent binding of the IgG antibodies of groups III and IV is required for neutralization of viral infectivity through a proposed mechanism by which these antibodies interfere with a low pH-induced conformational change resulting in inhibition of the fusion step of the viral replication process.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411245     DOI: 10.1007/bf01314232

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  20 in total

1.  The hydrolysis of rabbit y-globulin and antibodies with crystalline papain.

Authors:  R R PORTER
Journal:  Biochem J       Date:  1959-09       Impact factor: 3.857

2.  Coupling of enzymes to proteins with glutaraldehyde. Use of the conjugates for the detection of antigens and antibodies.

Authors:  S Avrameas
Journal:  Immunochemistry       Date:  1969-01

3.  Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus.

Authors:  H Kida; L E Brown; R G Webster
Journal:  Virology       Date:  1982-10-15       Impact factor: 3.616

4.  pH-dependent hemolysis by influenza, Semliki, Forest virus, and Sendai virus.

Authors:  J Lenard; D K Miller
Journal:  Virology       Date:  1981-04-30       Impact factor: 3.616

5.  Characterization of an influenza A virus from seals.

Authors:  R G Webster; V S Hinshaw; W J Bean; K L Van Wyke; J R Geraci; D J St Aubin; G Petursson
Journal:  Virology       Date:  1981-09       Impact factor: 3.616

6.  Influenza viruses cause hemolysis and fusion of cells.

Authors:  R T Huang; R Rott; H D Klenk
Journal:  Virology       Date:  1981-04-15       Impact factor: 3.616

7.  Studies on the mechanism of neutralization of influenza virus by antibody: evidence that neutralizing antibody (anti-haemagglutinin) inactivates influenza virus in vivo by inhibiting virion transcriptase activity.

Authors:  R D Possee; G C Schild; N J Dimmock
Journal:  J Gen Virol       Date:  1982-02       Impact factor: 3.891

8.  Monoclonal anti-hemagglutinin antibodies detect irreversible antigenic alterations that coincide with the acid activation of influenza virus A/PR/834-mediated hemolysis.

Authors:  J W Yewdell; W Gerhard; T Bachi
Journal:  J Virol       Date:  1983-10       Impact factor: 5.103

9.  Changes in the antigenicity of the hemagglutinin molecule of H3 influenza virus at acidic pH.

Authors:  R G Webster; L E Brown; D C Jackson
Journal:  Virology       Date:  1983-04-30       Impact factor: 3.616

10.  Infectious cell entry mechanism of influenza virus.

Authors:  A Yoshimura; K Kuroda; K Kawasaki; S Yamashina; T Maeda; S Ohnishi
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

View more
  4 in total

Review 1.  Genetic and structural determinants of virus neutralizing antibodies.

Authors:  J E Crowe; R O Suara; S Brock; N Kallewaard; F House; J H Weitkamp
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Relative antigenicity in mice of H1N1, H3N2 and B strains present in inactivated influenza virus vaccines.

Authors:  M L Profeta; M Ruggeri
Journal:  Eur J Epidemiol       Date:  1987-03       Impact factor: 8.082

3.  A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes.

Authors:  Nicola Clementi; Donata De Marco; Nicasio Mancini; Laura Solforosi; Guisella J Moreno; Larisa V Gubareva; Vasiliy Mishin; Andrea Di Pietro; Elisa Vicenzi; Antonio G Siccardi; Massimo Clementi; Roberto Burioni
Journal:  PLoS One       Date:  2011-12-05       Impact factor: 3.240

4.  A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses.

Authors:  Donata De Marco; Nicola Clementi; Nicasio Mancini; Laura Solforosi; Guisella J Moreno; Xiangjie Sun; Terrence M Tumpey; Larisa V Gubareva; Vasiliy Mishin; Massimo Clementi; Roberto Burioni
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.